Pharma-Bio Serv (PBSV) Upgraded at ValuEngine
ValuEngine upgraded shares of Pharma-Bio Serv (OTCMKTS:PBSV) from a strong sell rating to a sell rating in a report published on Friday morning.
Pharma-Bio Serv (PBSV) opened at $0.52 on Friday. Pharma-Bio Serv has a 12 month low of $0.32 and a 12 month high of $0.99.
TRADEMARK VIOLATION WARNING: “Pharma-Bio Serv (PBSV) Upgraded at ValuEngine” was published by TheOlympiaReport and is owned by of TheOlympiaReport. If you are viewing this piece of content on another publication, it was copied illegally and republished in violation of United States & international trademark and copyright law. The original version of this piece of content can be read at https://theolympiareport.com/2017/12/05/pharma-bio-serv-pbsv-upgraded-at-valuengine.html.
About Pharma-Bio Serv
Pharma-Bio Serv, Inc is a compliance and technology transfer services consulting company. The Company operates through four segments: Puerto Rico technical compliance consulting, United States technical compliance consulting, Europe technical compliance consulting, and Puerto Rico microbiological and chemical laboratory testing division (Lab).
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Pharma-Bio Serv Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharma-Bio Serv Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.